The Valley Desk

Clinical trial reportBloodPublished

A decade of ibrutinib for CLL with and without TP53 aberration: final report on an investigator-sponsored phase 2 study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Pennsylvania Hospital, University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Blood
Published
Subject terms
Humans; Piperidines; Pyrazoles; Pyrimidines; Adenine; Protein Kinase Inhibitors; Follow-Up Studies; Mutation; Aged; Aged, 80 and over; Middle Aged; Female
PubMed ID
41405491
PubMed Central ID
PMC13077481
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal